Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Medtronic
Mallinckrodt
Colorcon
Express Scripts

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

Drugs in MeSH Category Muscarinic Antagonists

See Plans and Pricing

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sunovion Pharms Inc SEEBRI glycopyrrolate POWDER;INHALATION 207923-001 Oct 29, 2015 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Somerset Theraps Llc GLYCOPYRROLATE glycopyrrolate INJECTABLE;INJECTION 207639-001 Jun 23, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Apotex Corp TOLTERODINE TARTRATE tolterodine tartrate TABLET;ORAL 200164-002 Sep 25, 2012 DISCN No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd GLYCOPYRROLATE glycopyrrolate TABLET;ORAL 040847-001 Mar 21, 2008 AA RX No No   Start Trial   Start Trial   Start Trial
Alkem Labs Ltd SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 210224-001 May 20, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Mikart TRIHEXYPHENIDYL HYDROCHLORIDE trihexyphenidyl hydrochloride ELIXIR;ORAL 040251-001 Sep 27, 1999 AA RX No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Express Scripts
Merck
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.